PDF(300 KB)
Non-Communicable Diseases During the COVID-19 Pandemic and Beyond
Xiong-Fei Pan, Juan Yang, Ying Wen, Naishi Li, Simiao Chen, An Pan
PDF(300 KB)
PDF(300 KB)
Non-Communicable Diseases During the COVID-19 Pandemic and Beyond
| [[1]] |
World Health Organization. Timeline: WHO’s COVID-19 response [Internet]. Geneva: World Health Organization; 2021 [cited 2021 Apr 1]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/interactivetimeline.
|
| [[2]] |
Johns Hopkins University and Medicine Coronavirus Resource Center. COVID19 dashboard by the Center for Systems Science and Engineering at Johns Hopkins University 2021 [Internet]. Baltimore: Johns Hopkins University and Medicine Coronavirus Resource Center; [cited 2021 Apr 1]. Available from: https://coronavirus.jhu.edu/map.html.
|
| [[3]] |
Lancet COVID-19 Commissioners, Task Force Chairs, Commission Secretariat. Lancet COVID-19 Commission Statement on the occasion of the 75th session of the UN General Assembly. Lancet 2020;396(10257):1102–24.
|
| [[4]] |
Barron E, Bakhai C, Kar P, Weaver A, Bradley D, Ismail H, et al. Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study. Lancet Diabetes Endocrinol 2020;8(10):813–22.
|
| [[5]] |
Nishiga M, Wang DW, Han Y, Lewis DB, Wu JC. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol 2020;17(9):543–58.
|
| [[6]] |
Marshall M. The lasting misery of coronavirus long-haulers. Nature 2020;585 (7825):339–41.
|
| [[7]] |
US National Center for Immunization and Respiratory Diseases. Evidence used to update the list of underlying medical conditions that increase a person’s risk of severe illness from COVID-19 [Internet]. Bethesda: US National Center for Immunization and Respiratory Diseases; 2021 [cited 2021 Apr 1]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/ evidence-table.html.
|
| [[8]] |
Alyammahi SK, Abdin SM, Alhamad DW, Elgendy SM, Altell AT, Omar HA. The dynamic association between COVID-19 and chronic disorders: an updated insight into prevalence, mechanisms and therapeutic modalities. Infect Genet Evol 2021;87:104647.
|
| [[9]] |
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395(10229):1054–62.
|
| [[10]] |
Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature 2020;584(7821):430–6.
|
| [[11]] |
Belanger MJ, Hill MA, Angelidi AM, Dalamaga M, Sowers JR, Mantzoros CS. Mantzoros COVID-19 and disparities in nutrition and obesity. N Engl J Med 2020;383(11):e69.
|
| [[12]] |
Chu DK, Akl EA, Duda S, Solo K, Yaacoub S, Schünemann HJ, et al. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and metaanalysis. Lancet 2020;395(10242):1973–87.
|
| [[13]] |
O’Driscoll M, Ribeiro Dos Santos G, Wang L, Cummings DAT, Azman AS, Paireau J, et al. Age-specific mortality and immunity patterns of SARS-CoV-2. Nature 2021;590(7844):140–5.
|
| [[14]] |
Mattioli AV, Ballerini Puviani M, Nasi M, Farinetti A. COVID-19 pandemic: the effects of quarantine on cardiovascular risk. Eur J Clin Nutr 2020;74(6):852–5.
|
| [[15]] |
Kluge HHP, Wickramasinghe K, Rippin HL, Mendes R, Peters DH, Kontsevaya A, et al. Prevention and control of non-communicable diseases in the COVID-19 response. Lancet 2020;395(10238):1678–80.
|
| [[16]] |
Marmot M, Bell R. Social determinants and non-communicable diseases: time for integrated action. BMJ 2019;364:l251.
|
| [[17]] |
Gray DM, Anyane-Yeboa A, Balzora S, Issaka RB, May FP. COVID-19 and the other pandemic: populations made vulnerable by systemic inequity. Nat Rev Gastroenterol Hepatol 2020;17(9):520–2.
|
| [[18]] |
Abrams EM, Szefler SJ. COVID-19 and the impact of social determinants of health. Lancet Respir Med 2020;8(7):659–61.
|
| [[19]] |
Horton R. Offline: COVID-19 is not a pandemic. Lancet 2020;396(10255):874.
|
| [[20]] |
World Health Organization. The impact of the COVID-19 pandemic on noncommunicable disease resources and services: results of a rapid assessment [Internet]. Geneva: World Health Organization; 2020 [cited 2021 Apr 1]. Available from: https://www.who.int/pub.
|
| [[21]] |
University of Washington Institute for Health Metrics and Evaluation. Global health data exchange [Internet]. Seattle: University of Washington Institute for Health Metrics and Evaluation; 2021 [cited 2021 Apr 1]. Available from: http://ghdx.healthdata.org/gbd-results-tool.
|
| [[22]] |
Nugent R, Bertram MY, Jan S, Niessen LW, Sassi F, Jamison DT, et al. Investing in non-communicable disease prevention and management to advance the Sustainable Development Goals. Lancet 2018;391(10134):2029–35.
|
| [[23]] |
Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19): summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020;323 (13):1239–42.
|
| [[24]] |
You J. Lessons from South Korea’s COVID-19 policy response. Am Rev Public Adm 2020;50(6–7):801–8.
|
| [[25]] |
Chen S, Zhang Z, Yang J, Wang J, Zhai X, Bärnighausen T, et al. Fangcang shelter hospitals: a novel concept for responding to public health emergencies. Lancet 2020;395(10232):1305–14.
|
| [[26]] |
Meng Q, Mills A, Wang L, Han Q. What can we learn from China’s health system reform? BMJ 2019;365:12349.
|
| [[27]] |
Pan A, Liu L, Wang C, Guo H, Hao X, Wang Q, et al. Association of public health interventions with the epidemiology of the COVID-19. JAMA 2020;323 (19):1915–23.
|
| [[28]] |
Jiang T, Wang H, Gao GF, Jiang X. Wearing face masks—the simple and effective way to block the infection source of COVID-19. China CDC Weekly 2020;2 (16):268–9.
|
| [[29]] |
World Health Organization. Tackling NCDs: ‘best buys’ and other recommended interventions for the prevention and control of noncommunicable diseases [Internet]. Geneva: World Health Organization; 2017 [cited 2021 Apr 1]. Available from: https://apps.who.int/iris/handle/ 10665/259232.
|
| [[30]] |
Chen S, Jin Z, Bloom DE. Act early to prevent infections and save lives: causal impact of diagnostic efficiency on the COVID-19 pandemic [Internet]. Bonn: IZA–Institute of Labor Economics; 2020 [cited 2021 Apr 1]. Available from: https://www.iza.org/publications/dp/13749/act-early-to-prevent-infectionsand-save-lives-causal-impact-of-diagnostic-efficiency-on-the-covid-19- pandemic.
|
| [[31]] |
Remais JV, Zeng G, Li G, Tian L, Engelgau MM. Convergence of noncommunicable and infectious diseases in low- and middle-income countries. Int J Epidemiol 2013;42(1):221–7.
|
| [[32]] |
Allen LN, Feigl AB. Reframing non-communicable diseases as socially transmitted conditions. Lancet Glob Health 2017;5(7):e644–6.
|
| [[33]] |
Sheldon TA, Wright J. Twin epidemics of COVID-19 and non-communicable disease. BMJ 2020;369:m2618.
|
| [[34]] |
Morens DM, Fauci AS. Emerging pandemic diseases: how we got to COVID-19. Cell 2020;182(5):1077–92.
|
| [[35]] |
Whitmee S, Haines A, Beyrer C, Boltz F, Capon AG, de Souza Dias BF, et al. Safeguarding human health in the Anthropocene epoch: report of The Rockefeller Foundation–Lancet Commission on planetary health. Lancet 2015;386(10007):1973–2028.
|
/
| 〈 |
|
〉 |
AI Summary
